Table 1.
Demographic and Descriptive Characteristics of Primary HIV Infection Participants and HIV-Uninfected Controls
| PHI (n = 92) | HIV-uninfected (n = 25) | P Value | |
|---|---|---|---|
| % Male | 95.2% | 80% | .03 |
| Age, years | 36 (28–46) | 43 (40–49) | .001 |
| Estimated days of infection | 92 (52–152) | … | … |
| CD4 count, cells/uL | 536 (392–682) | 836 (703–1056) | <.0001 |
| Log10 plasma VL | 4.6 (4.0–5.2) | … | … |
| Log10 CSF VL | 2.9 (2.0–3.6) | … | … |
| CSF protein, mg/dL | 41 (32–53) | 47 (33–56) | .71 |
| CSF WBCs, cells/uL | 6 (2–11) | 1 (0–2.5) | <.0001 |
| % ARS neuro symptoms | 8.7% | … | … |
Values are shown as median (IQR) except where noted.
Abbreviations: ARS, acute retroviral syndrome; CSF, cerebrospinal fluid; HIV, human immunodeficiency virus; PHI, primary HIV infection; VL, viral load; WBC, white blood cells.